Metabonomic study of rats exposed to cigarette sidestream smoke

Wen-liu Lian , Xian-zhe Shi , Jia Luo , Feng-lian Ren

Journal of Central South University ›› 2016, Vol. 23 ›› Issue (3) : 535 -543.

PDF
Journal of Central South University ›› 2016, Vol. 23 ›› Issue (3) : 535 -543. DOI: 10.1007/s11771-016-3100-6
Article

Metabonomic study of rats exposed to cigarette sidestream smoke

Author information +
History +
PDF

Abstract

A metabonomic approach was undertaken in order to detect urinary endogenous and exogenous metabolites and to evaluate the effects of passive exposure to cigarette sidestream smoke on rats. Urinary samples from three groups of rats were determined including control rats, rats treated with blended cigarettes (nonmenthol cigarettes) and rats treated with menthol cigarettes. The total urinary 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), total 1-hydroxypyrene (1-HOP) and 3-hydroxybenzo[a] pyrene (3-HOBaP) were determined for assessing exposure to cigarette sidestream smoke toxins. Urinary endogenous metabolites in the three groups of rats were also analyzed and the data were processed by chemometrics. Eleven endogenous metabolites were found and identified. Their relative levels were compared among the three groups. The results show that cigarette sidestream smoke has complex effect on rats. Blended cigarette group makes difference to menthol cigarette group in the rats’ urinary metabolic changes. Menthol adding to cigarettes has positive and negative effects on rats, respectively. The urinary metabolic profiling of menthol cigarette group is closer to that of control group.

Keywords

metabonomics / rats / urine / endogenous metabolites / exogenous metabolites

Cite this article

Download citation ▾
Wen-liu Lian, Xian-zhe Shi, Jia Luo, Feng-lian Ren. Metabonomic study of rats exposed to cigarette sidestream smoke. Journal of Central South University, 2016, 23(3): 535-543 DOI:10.1007/s11771-016-3100-6

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

RockvilleM. D.Smoking and health: Report of the advisory committee to the surgeon general of the public health service [R], 1964Washington D CPublic Health Service

[2]

ChenJ.-m., HwangB.-f., ChenY.-c., Leo LeeY.. Active smoking, environmental tobacco smoke and bronchitic symptoms among adolescents in Taiwan: A prospective cohort study [J]. Preventive Medicine, 2014, 65: 116-121

[3]

YamamotoM. L., ChapmanA. M., SchiestlR. H.. Effects of side-stream tobacco smoke and smoke extract on glutathione-and oxidative DNA damage repair-deficient mice and blood cells [J]. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2013, 749(1/2): 58-65

[4]

WuM.-j., DaiY.-h., TuoS.-x., HuN.-n., LiY. C. X.-m.. Analysis of four tobacco-specific nitrosamines in mainstream cigarette smoke of Virginia cigarettes by LC-MS/MS [J]. Journal of Central South University of Techndogy, 2008, 15(5): 627-631

[5]

LianW.-l., RenF.-l., LiuQ., XieL.-y.. Evaluation of metal-doped manganese oxide octahedral molecular sieves in catalytic reduction of NOx from cigarette mainstream smoke [J]. Journal of Central South University of Techndogy, 2012, 19(4): 918-922

[6]

WyndeE. L., HoffmannD.. Smoking and lung cancer: Scientific challenges and opportunities [J]. Cancer Research, 1994, 54: 5284-5295

[7]

BlotW. J., FraumeniJ.Cancer epidemiology and prevention [J], 1996637

[8]

HechtS. S.. Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke [J]. Tobacco Control, 2003, 13: i48-i56

[9]

YankelevitzD. F., HenschkeC. I., YipR., BoffettaP., ShemeshJ., ChamM. D., NarulaJ., HechtH. S.. Second-hand tobacco smoke in never smokers is a significant risk factor for coronary artery [J]. JACC: Cardiovascular Imaging, 2013, 6(6): 651-657

[10]

NicholsonJ. K., LindonJ. C., HolmesE.. ‘Metabonomics’: Understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data [J]. Xenobiotica, 1999, 29(11): 1181-1189

[11]

GreefJ., StroobantP., van der HeidenR.. The role of analytical sciences in medical systems biology [J]. Current Opinion in Chemical Biology, 2004, 8: 559-565

[12]

EkmanD. R., KeunH. C., EadsC. D., FurnishC. M., MurrellR. N., RockettJ. C., DixD. J.. Metabolomic evaluation of rat liver and testis to characterize the toxicity of triazole fungicides [J]. Metabolomics, 2006, 2(2): 63-73

[13]

GibneyM. J., WalshM., BrennanL., RocheH. M., GermanB., –OmmenB.. Metabolomics in human nutrition: Opportunities and challenges [J]. The American Journal of Clinical Nutrition, 2005, 82: 497-503

[14]

ZhangF.-x., JiaZ.-h., GaoP., KongH.-w., LiX., ChenJ., YangQ., YinP.-y., WangJ.-s., LuX., LiF.-m., WuY.-l., XuG.-w.. Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry [J]. Talanta, 2009, 79: 836-844

[15]

GuoN., YangD.-w., WangX.-x., DaiJ.-g., WangM., LeiY.. Metabonomic study of chronic heart failure and effects of Chinese herbal decoction in rats [J]. Journal of Chromatography A, 2014, 1362: 89-101

[16]

TaoM., XiuD. R.. Metabonomic analysis of rats with acute heart rejection [J]. Transplantation proceedings, 2013, 45(2): 618-624

[17]

ZhaoY.-y., LiuJ., ChenaX.-l., BaiX., LinR.-c.. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS [J]. Clinica Chimica Acta, 2012, 413(5/6): 642-649

[18]

TagliattiV., ConotteR., LucaD., ColetJ.. Valproate-induced liver mitochondrial dysfunction in rats: A metabonomic approach [J]. Toxicology Letters, 2011, 205: s277

[19]

MattesW., YangX., OrrM. S., RichterP., MendrickD. L.. Biomarkers of tobacco smoke exposure [J]. Advances in Clinical Chemistry, 2014, 67: 1-45

[20]

YouF., ZhuL., HeL., RanL.-j., JinY., SunC.-j.. Simultaneous determination of seven metabolites of polycyclic aromatic hydrocarbons in human urine by online solid phase extraction-high performance liquid chromatography [J]. Chinese Journal of Analytical Chemistry, 2014, 42(12): 1723-1728

[21]

WangJ.-z., RoethigH. J., AppletonS., WerleyM., Muhammad-KahR., MendesP.. The effect of menthol containing cigarettes on adult smokers’ exposure to nicotine and carbon monoxide [J]. Regulatory Toxicology and Pharmacology, 2010, 57(1): 24-30

[22]

XiaY., McguffeyJ. E., BhattacharyyaS., SellergrenB., YilmazE., WangL., BernertJ. T.. Analysis of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine by extraction on a molecularly imprinted polymer column and liquid chromatography/atmospheric pressure ionization tandem mass spectrometry [J]. Analytical Chemistry, 2005, 77(23): 7639-7645

[23]

ChiangH.-c., HuangY.-k., ChenP.-f., ChangC.-c., WangC.-j., LinP.-p., LeeH.-l.. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone is correlated with 8-hydroxy-2’-deoxyguanosine in humans after exposure to environmental tobacco smoke [J]. Science of the Total Environment, 2012, 414: 134-139

[24]

PolanskaK., HankeW., DettbarnG., SobalaW., GromadzinskaJ., MagnusP., SeidelA.. The determination of polycyclic aromatic hydrocarbons in the urine of non-smoking Polish pregnant women [J]. Science of the Total Environment, 2014, 487: 102-109

[25]

SarkarM., Muhammad-KahR., LiangQ.-w., KapurS., FengS.-x., RoethigH.. Evaluation of spot urine as an alternative to 24 h urine collection for determination of biomarkers of exposure to cigarette smoke in adult smokers [J]. Environmental Toxicology and Pharmacology, 2013, 36(1): 108-114

[26]

HechtS. S., MurphyS. E., CarmellaS. G., LiS., JensenJ., LeC., JosephA. M., HatsukamiD. K.. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes [J]. Cancer Epidemiology, Biomarkers & Prevention, 2005, 14(3): 693-698

[27]

HechtS. S., MurphyS. E., StepanovI., NelsonH. H., YuanJ.-m.. Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai Cohort Study [J]. Cancer Letters, 2013, 334(1): 34-38

[28]

HatsukamiD. K., BenowitzN. L., RennardS. I., OnckenC., HechtS. S.. Biomarkers to assess the utility of potential reduced exposure tobacco products [J]. Nicotine Tobacco Research, 2006, 8: 600-622

[29]

HechtS. S.. Human urinary carcinogen metabolites: Biomarkers for investigating tobacco and cancer [J]. Carcinogenesis, 2002, 23: 907-922

[30]

HechtS. S., CarmellaS. G., LeK., MurphyS. E., LiY. S., LeC., JensenJ., HatsukamiD. K.. Effects of reduced cigarette smoking on levels of 1-hydroxypyrene in urine [J]. Cancer Epidemiology, Biomarkers & Prevention, 2004, 13(5): 834-842

[31]

VulimiriS. V., MisraM., HammJ. T., MitchellM., BergerA.. Effects of mainstream cigarette smoke on the global metabolome of human lung epithelial cells [J]. Chemical Research in Toxicology, 2009, 22(3): 492-503

[32]

ShiX.-z., HeZ.-h., DouA.-b., ZhangF.-x., LianW.-l., XuG.-w.. Effect of menthol cigarette on rats for metabonomics by liquid chromatography-mass spectrometry [J]. Journal of Chromatography, 2010, 28(8): 765-768

[33]

LianW.-l., HeZ.-h., RenF.-l., LuoJ.. Determination of 1-OHP and 3-OHBaP in human urine by UPLC [J]. Chemistry, 2010, 73(9): 842-845

[34]

WiklundS., JohanssonE., SjostromL., MellerowiczE. J., EdlundU., ShockcorJ. P., GottfriesJ., MoritzT., TryggJ.. Visualization of GC/TOF-MS-Based metabolomics data for identification of biochemically interesting compounds using OPLS class models [J]. Analytical Chemistry, 2008, 80: 115-122

[35]

RamadanD. J., JacobsD., GrigorovM., KochharS.. Metabolic profiling using principal component analysis, discriminant partial least squares, and genetic algorithms [J]. Talanta, 2006, 68: 1683-1691

[36]

WangY., WangJ. S., YaoM., ZahoX. J., FritscheJ., Schmitt-KopplinP., CaiZ. W., WanD. F., LuX., YangS. L., GuJ. R., HaringH. U., SchleicherE. D., LehmannR., XuG. W.. Metabonomics study on the effects of the ginsenoside Rg3 in a beta-cyclodextrin-based formulation on tumor-bearing rats by a fully automatic hydrophilic interaction/ reversed-phase column-switching HPLC-ESI-MS approach [J]. Analytical Chemistry, 2008, 80(12): 4680-4688

[37]

NapolitanoA., DelD., PetrozziL., Dell’AgnelloG., BelliniG., GambacciniG., BonuccelliU.. Pharmacokinetics and pharmacodynamics of L-Dopa after acute and 6-week tolcapone administration in patients with Parkinson’s disease [J]. Clinical Neuropharmacology, 1999, 22(1): 24-29

[38]

LundbergI., SollenbergJ.. Correlation of xylene exposure and methyl hippuric acid excretion in urine among paint industry workers [J]. Scandinavian Journal of Work, Environment & Health, 1986, 12: 149-153

[39]

JannA., StalonV. V., WauvenC., LeisingerT., HaasD.. N2-succinylated intermediates in an arginine catabolic pathway of Pseudomonas aeruginosa [J]. Proceedings of the National Acaddemy of Sciences, 1986, 83: 4937-4941

[40]

BlandiniF., FancelluR., MartignoniE., ManiaglliA., PacchettiC., SamueleA., NappiG.. Plasma homocysteine and l-DOPA metabolism in patients with Parkinson disease [J]. Clinical Chemistry, 2001, 47: 1102-1104

[41]

XuY., LabedanB., GlansdorffN.. Surprising arginine biosynthesis: A reappraisal of the enzymology and evolution of the pathway in microorganisms [J]. Microbiology and Molecular Biology Reviews, 2007, 71: 36-47

[42]

ZhengS., YuM., LuX., HuoT., GeL., YangJ., WuC., LiF.. Urinary metabonomic study on biochemical changes in chronic unpredictable mild stress model of depression [J]. Clinica Chimica Acta, 2010, 411(3/4): 204-209

[43]

KandyalaR., RaghavendraS. P. C., RajasekharanS. T.. Xylene: An overview of its health hazards and preventive measures [J]. Journal of Oral and Maxillofacial Pathology, 2010, 14(1): 1-5

[44]

RosenbergR. N., DimauroS., PaulsonH. L., PtacekL., NestlerE. J.The molecular and genetic basis of neurologic and psychiatric disease [J], 2007462-463

AI Summary AI Mindmap
PDF

95

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/